Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 2014-09-30 Declaration of Voting R…
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2014
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and is dated 30 September 2014. It details the shareholdings and voting rights attributed to various BlackRock entities in Fresenius SE & Co. KGaA as of 25 September 2014, referencing German Securities Trading Act (WpHG) sections (Sec. 21, 22). This content directly corresponds to the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official notifications regarding voting rights changes or status.
2014-09-30 English
Goldman Sachs - EMEA Leveraged Finance Conference:
Investor Presentation Classification · 99% confidence The document is titled 'Health Care Worldwide' and is explicitly labeled as a presentation given at the 'Goldman Sachs – 2014 EMEA Leveraged Finance Conference' on September 30, 2014. It contains an agenda, company overview, detailed segment breakdowns (Fresenius Medical Care, Kabi, Helios, Vamed), financial results presented in slides/tables, and a 'Safe Harbor Statement' typical of investor presentations. This structure and context strongly indicate that the document is an Investor Presentation (IP) delivered to an audience of financial professionals (leveraged finance conference attendees). It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a quarterly report (IR), but rather a presentation summarizing the company's status and outlook.
2014-09-30 English
Berenberg Bank & Goldman Sachs – 3rd German Corporate Conference:
Investor Presentation Classification · 98% confidence The document is titled as a presentation material, specifically referencing a 'Berenberg Bank & Goldman Sachs – 3rd German Corporate Conference September 23, 2014'. It contains slides with financial highlights, business updates ('Q2/2014 Business Update'), outlooks, and strategic information, typical of an investor presentation given at a conference. It is not a formal regulatory filing like a 10-K, nor is it a short announcement of a report (RPA/RNS). The content structure strongly aligns with an Investor Presentation (IP).
2014-09-23 English
Credit Suisse – Global Credit Products Conference:
Investor Presentation Classification · 99% confidence The document text is titled as a presentation given at the 'Credit Suisse – Global Credit Products Conference' on 'September 18, 2014'. It contains an agenda, forward-looking statements, and detailed financial and operational data broken down by business segments (Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed). This structure—a formal presentation deck used to communicate strategy and performance to investors/analysts at a conference—is characteristic of an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K or an Earnings Release (ER), but rather a detailed presentation package.
2014-09-18 English
Sanford C. Bernstein Strategic Decisions Conference:
Investor Presentation Classification · 98% confidence The document text contains a title slide indicating it is a presentation given at 'Sanford C. Bernstein's Pan-European Strategic Decisions Conference' on September 17, 2014. It includes financial highlights, segment breakdowns, business updates (Q2/2014), and a 2014 outlook, all structured as presentation slides with bullet points and tables. This format strongly suggests an Investor Presentation (IP) rather than a formal regulatory filing like a 10-K or an Earnings Release (ER) which typically contains more standardized financial statements and less marketing/strategic narrative structure. The reference to 'conference call materials' further supports this being presentation material.
2014-09-17 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains specific details about transactions made by a person in a managerial position ('Dr. Ulf M. Schneider, Position: Member of a managing body'). It reports the exercise of stock options and subsequent sale of shares, which falls directly under the definition of insider trading reports. This corresponds precisely to the 'Director's Dealing' category (DIRS). The document length is short (1496 chars), but the content is the primary filing itself, not an announcement of a separate report.
2014-09-11 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.